ClassID:

20900

A61K38/08 - CPC Classification

Classification description:

Medicinal preparations containing peptides; Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof Peptides having 5 to 11 amino acids

Sub-classes:
Recent Application in this class:
#1
20260146102
2026-05-28

METHODS FOR MODULATING REGULATORY T CELLS

#2
20260144844
2026-05-28

PHARMACEUTICAL COMPOSITIONS FEATURING MIXTURES OF PEPTOIDS WITH AND WITHOUT TERMINAL ALIPHATIC MOIETIES

#3
20260139029
2026-05-21

THERAPEUTIC PEPTIDES AND METHODS FOR TREATING AUTOIMMUNE RELATED DISEASE

#4
20260137751
2026-05-21

ENTERICALLY DELIVERED BITTER OLIGOPEPTIDES FOR THE TREATMENT FOR TYPE 2 DIABETES

#5
20260137618
2026-05-21

Oral Film with Multiple Regions for Therapy of Periodontal and Dental Diseases or Disorders

#6
20260130966
2026-05-14

NOVEL THERAPEUTICS FOR PARASITIC INFECTION

#7
20260124269
2026-05-07

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

#8
20260124268
2026-05-07

QUORUM-SENSING INHIBITORS AND/OR POSTBIOTIC METABOLITES AND RELATED METHODS

#9
20260116954
2026-04-30

CHIMERIC PROTEIN COMPRISING AN ANTI-INFLUENZA VIRUS ANTIBODY MOIETY AND A MUCOADHESIVE PEPTIDE FRAGMENT FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

#10
20260115300
2026-04-30

GLYCOTARGETING THERAPEUTICS

#11
20260097092
2026-04-09

PHARMACEUTICAL COMPOSITION CONTAINING MITOCHONDRIA-TARGETING COMPOUND AS ACTIVE INGREDIENT FOR TREATING MACULAR DEGENERATION

#12
20260091083
2026-04-02

CYCLIC PROSAPOSIN PEPTIDES AND USES THEREOF

#13
20260091081
2026-04-02

A FORMULATION OF A CONJUGATE OF A TUBULYSIN ANALOG TO A CELL-BINDING MOLECULE

#14
20260091080
2026-04-02

COMPOSITIONS AND METHODS FOR TREATMENT

#15
20260091079
2026-04-02

SAPOSIN-A DERIVED PEPTIDES AND USES THEREOF

#16
20260091078
2026-04-02

OLIGOPEPTIDE THAT INHIBITS ANGIOGENESIS AND VASCULAR FUNCTION

#17
20260083817
2026-03-26

PEPTIDE COMPOSITIONS AND THEIR USE FOR THE TREATMENT OF SKIN AND MUCOUS MEMBRANE WOUNDS AND IN COSMETIC APPLICATIONS

#18
20260069694
2026-03-12

IDENTIFICATION OF HIGHLY IMMUNOSUPRESIVE TREG POPULATION IN TUMOR MICROENVIRONMENTS

#19
20260069651
2026-03-12

Application of Sardine Peptide Composition in Drug for Treating Allergic Rhinitis

#20
20260061025
2026-03-05

Polyhomoarginine (PHA) Polymers And Uses Thereof

#21
20260061024
2026-03-05

NASAL DELIVERY OF APIGENIN AND LINEAR PEPTIDE INHIBITORS OF MITOCHONDRIAL FISSION

#22
20260053885
2026-02-26

PHARMACEUTICAL COMPOSITIONS

#23
20260048145
2026-02-19

COMPOSITIONS AND METHODS FOR TREATING DRUG ADDICTION

#24
20260048097
2026-02-19

DRUG DELIVERY SYSTEMS COMPRISING AN INTRAOCULAR PRESSURE LOWERING AGENT, A NEUROTROPHIC AGENT, A C-TYPE NATRIURETIC PEPTIDE, A NATRIURETIC PEPTIDE RECEPTOR-B, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR OR A FAS-LIGAND INHIBITOR FOR TREATING GLAUCOMA OR OCULAR HYPERTENSION

#25
20260041777
2026-02-12

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR

#26
20260041747
2026-02-12

T CELL EPITOPES ASSOCIATED WITH TYPE 1 DIABETES

#27
20260034191
2026-02-05

LARAZOTIDE FORMULATIONS

#28
20260027166
2026-01-29

METHODS FOR TREATING AUTISM SPECTRUM DISORDER AND ASSOCIATED SYMPTOMS

#29
20260021164
2026-01-22

PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL

#30
20260014085
2026-01-15

MILK DERIVED EXOSOMES AND USES THEREOF

#31
20260007715
2026-01-08

WOUND CARE DEVICE

#32
20260007714
2026-01-08

METHODS FOR TREATING DISEASE AND REDUCING DRUG-INDUCED LIVER INJURY IN PATIENT POPULATIONS

#33
20260007593
2026-01-08

PREPARATION METHOD OF LONG-ACTING SUSTAINED AND CONTROLLED RELEASE IMPLANT

#34
20260000730
2026-01-01

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

#35
20250388633
2025-12-25

PHARMACEUTICAL ASSOCIATION OF GROWTH FACTOR RECEPTOR AGONIST AND ADHESION PROTEIN INHIBITOR FOR CONVERTING A NEOPLASTIC CELL INTO A NON-NEOPLASTIC CELL AND USES THEREOF

#36
20250388623
2025-12-25

PEPTIDE INHIBITOR AND USE THEREOF

#37
20250382328
2025-12-18

TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS

#38
20250381241
2025-12-18

METHODS AND COMPOSITIONS TO MODULATE RIOK2

#39
20250375500
2025-12-11

ANTIHYPERTENSIVE PEPTIDE PROBIOTIC GOAT MILK POWDER AND PREPARATION METHOD THEREOF

#40
20250367251
2025-12-04

SKELETON PROTECTION METHOD USING PEPTIDE

#41
20250361269
2025-11-27

PEPTIDE EXHIBITING MUSCLE LOSS PREVENTION AND MUSCLE MASS PROMOTION ACTIVITIES, AND USE THEREOF

#42
20250361268
2025-11-27

NOVEL ANTI-INFLAMMATORY PEPTIDE AND USE THEREOF

#43
20250360179
2025-11-27

PEPTIDE-IONIC LIQUID CONJUGATE FOR THE PREVENTION AND/OR TREATMENT OF SKIN DISORDERS

#44
20250352609
2025-11-20

Methods For Treating Alzheimer's Disease or Dementia Using A Calcilytic And A Calcimimetic

#45
20250352608
2025-11-20

POLYPEPTIDES HAVING ANTI-INFLAMMATORY EFFECTS AND USES THEREOF

#46
20250352486
2025-11-20

NANOPARTICLES FOR USE IN THE TREATMENT OF INFECTIONS CAUSED BY BIOFILMS

#47
20250345447
2025-11-13

PHARMACEUTICAL COMPOSITION OF RECOMBINANT ANTI-HUMAN CLDN18.2 MONOCLONAL ANTIBODY-MMAE CONJUGATE

#48
20250345438
2025-11-13

PHARMACEUTICAL COMPOSITIONS AND RELATED METHODS OF DELIVERY

#49
20250345387
2025-11-13

CORONAVIRUS THERAPEUTICS AND TREATMENT METHODS

#50
20250345386
2025-11-13

MICAFUNGIN COMPOSITIONS

#51
20250345385
2025-11-13

MIXTURES AND FORMULATIONS COMPRISING AN ALKYL AMMONIUM EDTA SALT

#52
20250340591
2025-11-06

COMPOSITION FOR PREVENTING OR TREATING INFLAMMATORY BOWEL DISEASE CONTAINING NOVEL COMPOUND

#53
20250332217
2025-10-30

IMMUNE CHECKPOINT INHIBITOR COMBINATIONS

#54
20250332212
2025-10-30

METHOD FOR TREATING OR PREVENTING ALOPECIA

#55
20250325485
2025-10-23

STABLE COMPOSITIONS OF FOXY-5 HEXAPEPTIDE WITH HIGH SOLUBILITY

#56
20250325473
2025-10-23

COLLAGEN-IMPREGNATED DEVICES AND METHODS FOR TREATMENT OF CANCER

#57
20250312408
2025-10-09

NAP FOR SEX-SPECIFIC TREATMENT OF DISEASES

#58
20250304619
2025-10-02

INHIBITION OF PULMONARY FIBROSIS WITH NUTLIN-3A AND PEPTIDES

#59
20250302910
2025-10-02

DRY POWDER FORMULATION OF CAVEOLIN-1 PEPTIDES AND METHODS OF USE THEREOF

#60
20250302818
2025-10-02

TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS

#61
20250295727
2025-09-25

STABLE, READY-TO-ADMINISTER AQUEOUS FORMULATIONS OF DALBAVANCIN

#62
20250289852
2025-09-18

ANTIFUNGAL AGENTS AND USES THEREOF

#63
20250288638
2025-09-18

TYROSINE INHIBITORS WITH IMMUNOSUPPRESSIVE ACTIVITY IN HUMAN NEONATAL KERATINOCYTE PROGENITORS

#64
20250281568
2025-09-11

METHOD FOR TREATING OR PREVENTING DRUG-INDUCED LIVER INJURY WITH PEPTIDE COMPOSITION

#65
20250281565
2025-09-11

PROBIOTIC BACTERIAL MOLECULES AND THEIR USE IN METHODS TO TREAT/PREVENT INFECTION BY HARMFUL BACTERIA AND TO PROVIDE NUTRITIONAL HEALTH

#66
20250281531
2025-09-11

METHODS AND COMPOSITIONS FOR DETOXIFICATION OF CHRONIC EXPOSURE TO TOXINS

#67
20250281456
2025-09-11

METHODS OF TREATING CANCER BY INHIBITING BACTERIAL DNAK TO RESTORE ACTIVITIES OF ANTICANCER DRUGS

#68
20250281423
2025-09-11

VESICLES AND USES THEREOF

#69
20250276998
2025-09-04

NOVEL DAROBACTIN DERIVATIVES

#70
20250276032
2025-09-04

COMPOSITIONS AND METHODS FOR TREATMENT

#71
20250270255
2025-08-28

CASPASE-2 INHIBITOR COMPOUNDS

#72
20250269058
2025-08-28

GENE THERAPY FOR TREATING NEURODEGENERATIVE DISEASES

#73
20250268977
2025-08-28

COMPOSITIONS AND METHODS FOR PROTECTING TYPE 2 ALVEOLAR EPITHELIAL CELLS (AEC2)

#74
20250268976
2025-08-28

BROAD-SPECTRUM PEPTOIDS FOR TREATMENT OR PREVENTION OF WOUND INFECTIONS, AND COMPOSITIONS AND METHODS OF USE THEREOF

#75
20250268975
2025-08-28

PEPTOIDS FOR TREATING FILOVIRIDAE INFECTIONS

#76
20250268948
2025-08-28

COMPOSITIONS AND METHODS FOR TREATING POST ACUTE SEQUELAE OF SARS-COV-2 INFECTION (LONG COVID)

#77
20250268836
2025-08-28

MICROSPHERE FORMULATIONS COMPRISING MULTIPLE NON-IDENTICAL PEPTIDES AND METHODS FOR MAKING THE SAME

#78
20250268809
2025-08-28

BROAD-SPECTRUM PEPTOIDS FOR ORAL AND DENTAL HYGIENE, AND COMPOSITIONS AND METHODS OF USE THEREOF

#79
20250264471
2025-08-21

AKT-SPECIFIC CAPTURE AGENTS, COMPOSITIONS, AND METHODS OF USING AND MAKING

#80
20250263433
2025-08-21

METHODS FOR REDUCING CD36 EXPRESSION

#81
20250262272
2025-08-21

PEPTIDES AND METHODS OF USE THEREOF IN TREATING SKIN DISEASES

#82
20250241981
2025-07-31

NOVEL COMPOSITION

#83
20250241976
2025-07-31

ADMINISTRATION OF AN ANTICANCER PEPTIDE

#84
20250235542
2025-07-24

POLYPEPTIDES HAVING ANTI-SENESCENT EFFECTS AND USES THEREOF

#85
20250228979
2025-07-17

BIOLOGICAL DEVICES AND COMPOSITIONS FOR INCREASING HAIR GROWTH AND METHODS OF USE THEREOF

#86
20250228915
2025-07-17

DISTINCT CD8+ T CELL PROGRAMMING IN THE TUMOR MICROENVIRONMENT CONTRIBUTES TO SEX BIAS IN CANCER

#87
20250213646
2025-07-03

BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TREATING SKIN

#88
20250213645
2025-07-03

PHARMACEUTICAL COMPOSITION FOR MODULATING IMMUNE RESPONSE

#89
20250213644
2025-07-03

COMPOSITIONS AND METHODS FOR TREATMENT OF BONE-RELATED DISEASE OR DISORDER

#90
20250213643
2025-07-03

COMPOSITIONS AND METHOD FOR OPTIMIZED PEPTIDE VACCINES USING RESIDUE OPTIMIZATION

#91
20250205302
2025-06-26

COMPOSITIONS AND METHODS FOR THE TREATMENT OF NEURODAMAGE

#92
20250195605
2025-06-19

Methods and Compositions for Use of a Chemokine Receptor Antagonist Peptide to Treat Addiction, Substance Abuse Disorders or Symptoms Thereof

#93
20250195604
2025-06-19

Compositions and Methods of Treatment of Certain Vasculitis Syndromes

#94
20250195603
2025-06-19

COMPOSITION FOR PREVENTING OR TREATING DENTAL CARIES

#95
20250195602
2025-06-19

Compositions and Methods for Treating Neuropathy

#96
20250186599
2025-06-12

BLOCK COPOLYMERS

#97
20250186571
2025-06-12

EPITOPE-TARGETED PEPTIDE IMMUNOSTIMULANTS

#98
20250186536
2025-06-12

SUSTAINED RELEASE PEPTIDE FORMULATIONS

#99
20250177492
2025-06-05

PIC1 INHIBITION OF MYELOPEROXIDASE OXIDATIVE ACTIVITY IN AN ANIMAL MODEL

#100
20250170253
2025-05-29

CONJUGATES FOR TREATING DISEASES CAUSED BY PSMA EXPRESSING CELLS

#101
20250170204
2025-05-29

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

#102
20250161401
2025-05-22

METHODS AND COMPOSITIONS FOR THE PREVENTION AND TREATMENT OF DUCHENNE MUSCULAR DYSTROPHY

#103
20250152703
2025-05-15

COMPOSITIONS FOR STIMULATION OF MAMMALIAN INNATE IMMUNE RESISTANCE TO PATHOGENS

#104
20250152659
2025-05-15

METHOD FOR PREVENTING OR TREATING PARKINSON'S DISEASE

#105
20250152658
2025-05-15

CYCLIC PEPTIDE FOR TRAPPING INTERLEUKIN-1 BETA

#106
20250144192
2025-05-08

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST BREAST CANCER AND OTHER CANCERS

#107
20250144166
2025-05-08

COMPOSITIONS AND METHODS FOR INHIBITING RHO KINASE

#108
20250136987
2025-05-01

CHANNEL MODULATORS

#109
20250136669
2025-05-01

VHH ANTIBODY

#110
20250134948
2025-05-01

METHOD OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

#111
20250134794
2025-05-01

BIOACTIVE WALNUT PEPTIDES AND COMPOSITIONS FOR TOPICAL TREATMENT OF SKIN

#112
20250127845
2025-04-24

MEDICINAL USES OF OLIGOPEPTIDES IN COMBINATION WITH AN ANTIANDROGEN

#113
20250127844
2025-04-24

PEPTIDE HAVING HAIR LOSS PREVENTION OR HAIR GROWTH PROMOTION ACTIVITY AND USE THEREOF

#114
20250127843
2025-04-24

ADRENOCORTICOTROPIC HORMONE PEPTIDE COMPOSITIONS AND METHODS OF USE

#115
20250127842
2025-04-24

IMMUNE CHECKPOINT TARGETING THERAPEUTIC NANOPARTICLES

#116
20250123282
2025-04-17

METHODS FOR EVALUATION AND TREATMENT OF TYROSINE KINASE INHIBITOR (TKI)-RESISTANT ACUTE MYELOID LEUKEMIA

#117
20250114543
2025-04-10

INTRANASAL ADMINISTRATION

#118
20250114430
2025-04-10

MODIFIED PEPTIDOMIMETICS AND METHODS OF USE

#119
20250109167
2025-04-03

METHODS FOR THE TREATMENT OF MITOCHONDRIAL DISEASE

#120
20250090676
2025-03-20

ANTI-FOLATE RECEPTOR ALPHA ANTIBODY CONJUGATES AND THEIR USES

#121
20250090670
2025-03-20

DRUG DELIVERY SYSTEMS COMPRISING A NEUROTROPHIC AGENT, AN APOPTOSIS SIGNALING FRAGMENT INHIBITOR (FAS) OR FAS LIGAND (FASL) INHIBITOR, A TUMOR NECROSIS FACTOR-ALPHA (TNF-ALPHA) OR TNF RECEPTOR INHIBITOR, A MITOCHONDRIAL PEPTIDE, AN OLIGONUCLEOTIDE, A CHEMOKINE INHIBITOR, OR A CYSTEINE-ASPARTIC PROTEASE INHIBITOR

#122
20250082718
2025-03-13

SUSTAINED RELEASE FORMULATION COMPRISING OCTREOTIDE AND TWO OR MORE POLYLACTIDE-CO-GLYCOLIDE POLYMERS

#123
20250082715
2025-03-13

COMPOSITIONS AND METHODS FOR TREATMENT OF ACUTE LUNG INJURY

#124
20250066489
2025-02-27

MONOCLONAL ANTIBODIES AGAINST HER2 EPITOPE AND METHODS OF USE THEREOF

#125
20250064786
2025-02-27

Methods and Compositions for Delivery of Biotin to Mitochondria

#126
20250057910
2025-02-20

Application of Polypeptide in Preparation of Product for Preventing or Treating Skin Injury Diseases

#127
20250057802
2025-02-20

BROAD-SPECTRUM ANTIVIRAL DRUGS

#128
20250057791
2025-02-20

PROTECTION AGAINST ARTHROPOD PARASITES WITH PURINERGIC RECEPTOR (OPR) ANTAGONISTS

#129
20250049936
2025-02-13

BIOORTHOGONAL COMPOSITIONS

#130
20250042944
2025-02-06

SQUID-DERIVED PEPTIDES AND USES THEREOF

#131
20250041377
2025-02-06

PHARMACEUTICAL USE

#132
20250034235
2025-01-30

COMPOSITIONS FOR PREVENTING OR TREATING INFLUENZA INFECTIONS

#133
20250032573
2025-01-30

IMMUNITY-ENHANCING PEPTIDE ANALOGS AND USES THEREOF

#134
20250032532
2025-01-30

COMBINATION OF OCTAPEPTIDE AND HIGH MOLECULAR WEIGHT HYALURONIC ACID FOR TOPICAL APPLICATION

#135
20250025525
2025-01-23

OCTAPEPTIDE FOR TOPICAL APPLICATION

#136
20250019402
2025-01-16

PHARMACOKINETICS AND CHOLECYSTOKININ-2 RECEPTOR (CCK2R) TARGETING FOR DIAGNOSIS AND THERAPY

#137
20250019400
2025-01-16

POLYPEPTIDE AND COSMETIC COMPOSITION OR PHARMACEUTICAL COMPOSITION AND USE THEREOF

#138
20250017954
2025-01-16

Formulations and Methods for Treating Symptoms of Menopause

#139
20250017899
2025-01-16

METHOD OF TREATING CANCER WITH COMBINATIONS OF HISTONE DEACETYLASE INHIBITORS (HDACI) SUBSTANCES

#140
20250011363
2025-01-09

OPTIMIZED SHORTENED PEPTIDE THAT BINDS TO ACETYLCHOLINE RECEPTOR, AND USE THEREOF

#141
20250009747
2025-01-09

ENDOTHELIN RECEPTOR ANTAGONISTS FOR USE IN TREATING OR PREVENTING MUSCLE FIBROSIS

#142
20250009640
2025-01-09

METHODS FOR IMPROVING SKIN CONDITION, HAIR HEALTH, ANTI-INFLAMMATION ACTIVITY, CARDIOVASCULAR HEALTH, ANTI-OXIDATION ACTIVITY, ANTI-AGING ACTIVITY, AND/OR RELIEVING BODY FATIGUE BY USING YEAST POWDER RICH IN NICOTINAMIDE MONONUCLEOTIDE

#143
20250002533
2025-01-02

PEPTIDE AND ITS USES

#144
20250000931
2025-01-02

PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING PAIN, COMPRISING GR82334 AS ACTIVE INGREDIENT

#145
20240424054
2024-12-26

CEACAM BASED ANTIBACTERIAL AGENTS

#146
20240424053
2024-12-26

METHODS AND COMPOSITIONS FOR PROVIDING MYOCARDIAL PROTECTION AND TREATING MYOCARDIAL STRESS AND FIBROSIS

#147
20240415955
2024-12-19

NOVEL IMMUNOTHERAPEUTIC COMPOSITION AND USES THEREOF

#148
20240415921
2024-12-19

METHODS OF TREATING CANCER BY TARGETING TUMOR-ASSOCIATED MACROPHAGES

#149
20240415920
2024-12-19

PEPTIDE HAVING ACTIVITY OF PREVENTING HAIR LOSS OR PROMOTING HAIR GROWTH, AND USE THEREOF

#150
20240415919
2024-12-19

COMPOSITIONS AND METHODS FOR TREATMENT OF AUTOIMMUNE DISORDERS AND CANCER

#151
20240415838
2024-12-19

USE OF TREM-1 INHIBITORS FOR TREATMENT, ELIMINATION AND ERADICATION OF HIV-1 INFECTION

#152
20240415806
2024-12-19

METHODS OF TREATING PRADER-WILLI SYNDROME

#153
20240415798
2024-12-19

COMPOSITIONS AND METHODS FOR TREATING MUCOSITIS

#154
20240391955
2024-11-28

PEPTIDE HAVING ANTI-AGING ACTIVITY, AND USE THEREOF

#155
20240390490
2024-11-28

PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS

#156
20240390455
2024-11-28

METHODS AND COMPOSITIONS FOR TREATING CANCERS AND OTHER PROLIFERATIVE DISORDERS

#157
20240390453
2024-11-28

PEPTIDE HAVING HAIR LOSS PREVENTION OR HAIR GROWTH PROMOTION ACTIVITY, AND USE THEREOF

#158
20240390452
2024-11-28

Protective Agent Against Endothelial Dysfunction

#159
20240382557
2024-11-21

INHIBITION OF TUMOR NECROSIS FACTOR, PRO-INFLAMMATORY CYTOKINES AND OTHER INFLAMMATORY RESPONSE MEDIATORS

#160
20240374686
2024-11-14

PEPTIDES AND METHODS FOR TREATING DISEASES

#161
20240368220
2024-11-07

IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF

#162
20240366735
2024-11-07

OCULAR ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE THEREOF

#163
20240358824
2024-10-31

COMPOSITIONS AND METHODS FOR TREATING VIRAL INFECTIONS THROUGH STIMULATED INNATE IMMUNITY IN COMBINATION WITH ANTIVIRAL COMPOUNDS

#164
20240358791
2024-10-31

PEPTIDES AND METHODS OF TREATING DYSTROPHY-RELATED DISORDERS USING THE SAME

#165
20240358790
2024-10-31

COMPOSITIONS AND METHODS FOR TREATING AUTOIMMUNITY, INCLUDING AUTOIMMUNITY ASSOCIATED WITH CANCER AND CANCER THERAPY

#166
20240350602
2024-10-24

NOVEL PEPTIDES & COMBINATION OF PEPTIDES AS TARGETS OR ACTIVE INGREDIENTS FOR USE IN IMMUNOTHERAPY AGAINST AML & OTHER CANCERS

#167
20240350580
2024-10-24

COMPOSITIONS AND METHOD FOR TREATING ACUTE RADIATION SYNDROME

#168
20240350578
2024-10-24

FUNCTIONAL OUTCOMES AFTER SPINAL CORD INJURY

#169
20240343765
2024-10-17

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

#170
20240342290
2024-10-17

Polypeptides having anti-senescent effects and uses thereof

#171
20240342238
2024-10-17

PEPTIDE HAVING OBESITY AND MUSCLE LOSS INHIBITORY ACTIVITIES, AND USE THEREOF

#172
20240335499
2024-10-10

PEPTIDE HAVING ANTIDIABETIC ACTIVITY AND USE THEREOF

#173
20240325559
2024-10-03

STABLE ANTI-CD79B IMMUNOCONJUGATE FORMULATIONS

#174
20240325552
2024-10-03

BLOCK COPOLYMERS

#175
20240325504
2024-10-03

TREATMENT

#176
20240325486
2024-10-03

METHODS FOR TREATING SYMPTOMS OF DRY EYE DISEASE

#177
20240325463
2024-10-03

COMPOSITIONS AND METHODS FOR TREATING OR PREVENTING INTESTINAL PARACELLULAR PERMEABILITY

#178
20240325460
2024-10-03

MOLECULAR BACTERIOTHERAPY TO CONTROL SKIN ENZYMATIC ACTIVITY

#179
20240325432
2024-10-03

COMPOSITION AND METHODS OF TREATMENT USING TRANSDERMAL SUPPLEMENTATION

#180
20240316142
2024-09-26

METHODS OF TREATING PROSTATE CANCER WITH GnRH ANTAGONIST

#181
20240316141
2024-09-26

The Use of Thiourea and Thiourea Derivatives As Potentiators of Antibacterial Activity of Peptoids

#182
20240307482
2024-09-19

TOPICAL COMPOSITIONS

#183
20240301427
2024-09-12

Treatment for Skeletal Diseases Caused by Intracellular Protein Trafficking Defects

#184
20240301141
2024-09-12

SILICONE POLYMER COMPOUND AND TRANSDERMAL DELIVERY SYSTEM COMPRISING SAME

#185
20240299552
2024-09-12

Pharmaceutical Composition of GLP-1/GLP-2 Dual Agonists

#186
20240299487
2024-09-12

ANTIVIRAL COMPOSITION COMPRISING A NUCLEOLIN-BINDING PEPTIDE

#187
20240294602
2024-09-05

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#188
20240293506
2024-09-05

Immune checkpoint inhibitor combinations

#189
20240293500
2024-09-05

PEPTIDE HAVING ANTICANCER ACTIVITY, AND USE THEREOF

#190
20240293499
2024-09-05

VISTA AGONISTS AND RELATED COMPOSITIONS AND METHODS

#191
20240293473
2024-09-05

METHODS FOR DIAGNOSIS AND TREATMENT OF TYPE 1 DIABETES

#192
20240293427
2024-09-05

PHARMACEUTICAL KIT FOR PARENTERAL CO-ADMINISTRATION

#193
20240293418
2024-09-05

COMBINATION THERAPY FOR TREATING CANCER

#194
20240285723
2024-08-29

COMBINATION COMPOSITIONS FOR THE TREATMENT OF PATHOGEN INFECTIONS AND ASSOCIATED COMPLICATIONS

#195
20240285605
2024-08-29

DRIED COSMETIC PREPARATION FOR REHYDRATION AND USE

#196
20240279279
2024-08-22

PROTEIN-DERIVED PEPTIDE FOR IMPROVING IMMUNITY AGAINST 2019 NOVEL CORONAVIRUS (2019-nCoV) AND USE THEREOF

#197
20240277797
2024-08-22

METHOD FOR TREATING OR PREVENTING NEOVASCULAR EYE DISEASE

#198
20240270791
2024-08-15

ANTIMICROBIAL PEPTIDES

#199
20240269227
2024-08-15

CALCIUM-SENSING RECEPTOR AGONIST COMPOSITION AND APPLICATION THEREOF

#200
20240269226
2024-08-15

COMBINATION THERAPY WITH SEMAX AND CANNABIDIOL

#201
20240269225
2024-08-15

Dry powder formulation of caveolin-1 peptides and methods of use thereof

#202
20240269196
2024-08-15

RESPIRATORY TREATMENTS USING SALMONID OIL COMPOSITIONS

#203
20240269067
2024-08-15

TOPICAL AND PARENTERAL USE AND ADMINISTRATION OF SELF-ASSEMBLING AMPHIPHILIC PEPTIDE HYDROGELS

#204
20240262916
2024-08-08

METHODS AND COMPOSITIONS FOR TREATING CARDIOVASCULAR DISEASE

#205
20240261423
2024-08-08

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#206
20240252583
2024-08-01

Compositions and Methods for Treating Persistent Postsurgical Pain

#207
20240252582
2024-08-01

METHODS FOR TREATING AMBLYOPIA

#208
20240245749
2024-07-25

Method of treating diseases

#209
20240245748
2024-07-25

Method of treating diseases

#210
20240240189
2024-07-18

CANCER TREATMENT BY TARGETING PROTEINS OR INTERACTIONS OF EPHRINB-RGS3-KIF20A-SEPT7 AXIS

#211
20240238445
2024-07-18

INHIBITORS AND USES THEREOF

#212
20240238366
2024-07-18

alpha-SYNUCLEIN AGGREGATION INHIBITOR, PHARMACEUTICAL COMPOSITION FOR alpha-SYNUCLEIN DISEASE, AND USE THEREOF

#213
20240238363
2024-07-18

ORAL PEPTIDE ANTAGONISTS OF MULTIPLE CHEMOKINE RECEPTORS FOR REVERSING LOSS OF SYNAPSES AND DENDRITIC SPINES

#214
20240238362
2024-07-18

ANTI-OBESITY PEPTIDES AND USES THEREOF

#215
20240216465
2024-07-04

METHOD FOR TREATING REFRACTORY BRAIN TUMOR

#216
20240216464
2024-07-04

IL1RA DERIVED PEPTIDES FOR TREATMENT OF DIABETIC NEPHROPATHY

#217
20240207355
2024-06-27

PHARMACEUTICAL COMPOSITION FOR ENHANCING ANTICANCER EFFECT OF ANTICANCER DRUG

#218
20240207354
2024-06-27

ETELCALCETIDE FORMULATIONS

#219
20240207352
2024-06-27

COMPOSITIONS AND METHODS FOR MODULATING MAMMARY DISORDERS AND CONDITIONS

#220
20240206758
2024-06-27

METHODS AND APPARATUS FOR GUIDING MEDICAL CARE BASED ON DETECTED GASTRIC FUNCTION

#221
20240199693
2024-06-20

HEPTAPEPTIDE AMIDES FOR USE IN THE TREATMENT OF HMGB1-DEPENDENT DISEASES

#222
20240199692
2024-06-20

POLYPEPTIDE HAVING MMP2-INHIBITORY EFFECT

#223
20240197811
2024-06-20

ANTIMICROBIAL PEPTIDE STIMULATING SANITIZING COMPOSITION

#224
20240197608
2024-06-20

ACETYL SH-HEXAPEPTIDE-5 AMIDE ACETATE FOR USE IN THE TREATMENT OF HAIR LOSS DISORDERS AND AS A HAIR CARE AGENT

#225
20240190915
2024-06-13

PEPTIDES FOR THE TREATMENT OF CANCER

#226
20240190914
2024-06-13

METHOD OF TREATING MELANOCORTIN-4 RECEPTOR-ASSOCIATED DISORDERS IN HETEROZYGOUS CARRIERS

#227
20240189386
2024-06-13

COMPOSITION FOR ANTI-FATIGUE COMPRISING GREEN TEA PEPTIDE COMPOSITION

#228
20240189383
2024-06-13

Application of Inhibitors Targeting CD226 Molecules in Anti-Tumor Metastasis

#229
20240181071
2024-06-06

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#230
20240181000
2024-06-06

LGG-DERIVED PEPTIDES AND METHODS OF USE THEREOF

#231
20240180997
2024-06-06

PEPTIDE INHIBITORS OF NF KAPPA B AND USE THEREOF IN TREATMENT OF COVID-19 AND INFLAMMATORY DISEASES

#232
20240180996
2024-06-06

BRUISING AND FILLER COMPOSITIONS AND METHODS FOR USE

#233
20240180856
2024-06-06

COMPOSITIONS, DELIVERY SYSTEMS, AND METHODS USEFUL IN TUMOR THERAPY

#234
20240173423
2024-05-30

CYCLIC PEPTIDYL INHIBITORS OF CAL-PDZ BINDING DOMAIN

#235
20240173376
2024-05-30

TREM-1 INHIBITORS FOR THE TREATMENT OF MARFAN SYNDROME

#236
20240165196
2024-05-23

Beta-Lactamase Inhibitors

#237
20240165006
2024-05-23

DERMATOLOGICAL COMPOSTIONS AND USE THEREOF

#238
20240156977
2024-05-16

ANTI-EDB ANTIBODIES AND ANTIBODY-DRUG CONJUGATES

#239
20240156933
2024-05-16

COMBINATORIAL ANDROGEN DEPRIVATION WITH AN ANDROGEN RECEPTOR VACCINE

#240
20240156897
2024-05-16

COMPOSITION FOR CONTROLLED RELEASE OF THERAPEUTIC AGENTS

#241
20240150403
2024-05-09

TREATMENT OF NON-ALCOHOLIC FATTY LIVER DISEASE

#242
20240142468
2024-05-02

PROTEIN BIOMARKERS FOR DISEASES ASSOCIATED WITH THE CONTACT ACTIVATION SYSTEM

#243
20240139292
2024-05-02

COMPOSITIONS AND METHODS FOR TREATMENT OF SENSITIVE SKIN

#244
20240139279
2024-05-02

CYCLIC PROSAPOSIN PEPTIDES AND USES THEREOF

#245
20240139105
2024-05-02

PHARMACEUTICAL COMPOSITION CONTAINING GHRP-6

#246
20240132542
2024-04-25

TREATMENTS FOR DISEASES AND DISORDERS THAT INVOLVE OXIDATIVE STRESS

#247
20240123022
2024-04-18

A STABLE ANTI-ANGIOGENIC AND ANTI-INFLAMMATORY PHARMACEUTICAL FORMULATION AND PHARMACEUTICAL COMBINATION FOR TREATMENT AND PREVENTION OF PSORIASIS

#248
20240123021
2024-04-18

PHARMACEUTICAL COMPOSITIONS

#249
20240115652
2024-04-11

TISSUE OCCLUDING AGENT COMPRISING AN IEIKIEIKIEIKI PEPTIDE

#250
20240115651
2024-04-11

PEPTIDES FOR TREATING DISEASE AND REDUCING SYMPTOMS RELATED TO MULTIPLE SCLEROSIS

#251
20240108686
2024-04-04

DPEP-1 Binding Compositions and Methods of Use

#252
20240101995
2024-03-28

BIOACTIVE PEPTIDE MOLECULES DISCOVERED BY A COMBINATION OF BIOINFORMATICS TECHNIQUE AND CHEMICAL SYNTHESIS

#253
20240091301
2024-03-21

APLNR Modulators and Uses Thereof

#254
20240082343
2024-03-14

METHOD OF TREATING DISEASES

#255
20240082342
2024-03-14

PEPTIDE THERAPEUTICS FOR INCREASING LUNG CELL VIABILITY

#256
20240082341
2024-03-14

PEPTIDE FOR USE IN THE TREATMENT OR PREVENTION OF COVID-19

#257
20240082134
2024-03-14

Compositions and methods of use for treatment or improvement of the condition and appearance of skin

#258
20240059736
2024-02-22

Inhibition of pulmonary fibrosis with nutlin-3A and peptides

#259
20240051997
2024-02-15

SAP AND PEPTIDOMIMETIC COMPOSITIONS FOR REDUCING SYMPTOMS OF INFLAMMATION

#260
20240050515
2024-02-15

METHODS AND COMPOSITIONS FOR TREATING CD44+ CANCERS

#261
20240050364
2024-02-15

IMMUNOSTIMULATORY METHOD

#262
20240041973
2024-02-08

ORAL OCTREOTIDE ADMINISTERED IN COMBINATION WITH OTHER THERAPEUTIC AGENTS

#263
20240041972
2024-02-08

CONJUGATES FOR IMMUNOTHERAPY

#264
20240033319
2024-02-01

PEPTIDES FOR PREVENTING OR TREATING HEART AND BLOOD VESSEL DISEASES

#265
20240033318
2024-02-01

PEPTIDYL INHIBITORS OF CALCINEURIN-NFAT INTERACTION

#266
20240033317
2024-02-01

USES OF HYPOXIA-INDUCIBLE FACTOR INHIBITORS FOR TREATING TP53-MUTATED ACUTE MYELOID LEUKEMIA

#267
20240026007
2024-01-25

ANTIBODIES TARGETING A COMPLEX COMPRISING NON-CLASSICAL HLA-I AND NEOANTIGEN AND THEIR METHODS OF USE

#268
20240024409
2024-01-25

N-f-MLF DERIVATIVES THAT INHIBIT FORMYL PEPTIDE RECEPTORS FOR THE TREATMENT OF DISEASE

#269
20240024408
2024-01-25

METHODS AND COMPOSITIONS FOR PREVENTING OR TREATING LEBER'S HEREDITARY OPTIC NEUROPATHY

#270
20240016882
2024-01-18

AUTOPHAGY-INHIBITING PEPTIDE AND ORGANIC ACID SALT THEREOF ADDRESSING ISSUES OF VASCULAR PERMEABILITY

#271
20240016881
2024-01-18

Coronavirus Therapy

#272
20240016880
2024-01-18

COMPOSITIONS AND METHODS FOR INVASIVE AND NON-INVASIVE PROCEDURAL SKINCARE

#273
20240011991
2024-01-11

COMPOSITIONS AND METHODS FOR PREDICTING RISK OF MODERATE TO SEVERE COVID-19 DISEASE

#274
20240009264
2024-01-11

USE OF PEPTIDES AS THERAPEUTIC AGENT FOR AUTOIMMUNE DISEASES AND BONE DISEASES

#275
20240009257
2024-01-11

METHODS AND MATERIALS FOR TREATING CANCER

#276
20240000962
2024-01-04

Glycan-Interacting Compounds and Methods of Use

#277
20240000882
2024-01-04

COMPOSITIONS AND METHODS FOR BODY CONTOURING AND SURGICAL PROCEDURES

#278
20230416306
2023-12-28

WAFER LEVEL CHIP SCALE PACKAGE WITH RHOMBUS SHAPE

#279
20230414704
2023-12-28

Compositions Containing a Pharmacophore with Selectivity to Diseased Tissue and Methods of Making Same

#280
20230414702
2023-12-28

COMPOUNDS AND PHARMACEUTICAL USE THEREOF IN THE TREATMENT OF CANCER

#281
20230414701
2023-12-28

COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING COGNITIVE DYSFUNCTION DISEASE, COMPRISING PEPTIDE HAVING SYNAPTIC PLASTICITY CONTROL FUNCTION

#282
20230406902
2023-12-21

PEPTIDE MIMOTOPES OF CLAUDIN 18.2 AND USES THEREOF

#283
20230404992
2023-12-21

TOPICAL FORMULATIONS COMPRISING MONTELUKAST AND COMBINATIONS WITH MUSSEL ADHESIVE PROTEINS

#284
20230399361
2023-12-14

MACROCYCLIC PEPTIDES

#285
20230390355
2023-12-07

COMPOSITIONS AND METHODS RELATING TO ALOPECIA

#286
20230381275
2023-11-30

MUSCULAR FUNCTION IMPROVING AGENT FOR SKELETAL MUSCLE OF WHICH FUNCTION IS DEGRADED DUE TO AGING

#287
20230381266
2023-11-30

BACTERIAL-BINDING PEPTIDES FOR TREATMENT OF INFECTIOUS DISEASES AND RELATED INFLAMMATORY PROCESSES

#288
20230372647
2023-11-23

INTRANASAL ADMINISTRATION

#289
20230372515
2023-11-23

METHODS AND PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF CANCERS ASSOCIATED WITH ACTIVATION OF THE MAPK PATHWAY

#290
20230372436
2023-11-23

SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS

#291
20230364212
2023-11-16

Compositions and method for optimized peptide vaccines using residue optimization

#292
20230355708
2023-11-09

COMPOSITIONS FOR INHIBITING VIRAL ENTRY AND METHODS USING SAME

#293
20230355493
2023-11-09

TOPICAL COMPOSITION

#294
20230348563
2023-11-02

NOVEL PEPTIDES AND COMBINATION OF PEPTIDES FOR USE IN IMMUNOTHERAPY AGAINST VARIOUS TUMORS

#295
20230348534
2023-11-02

SAP AND PEPTIDOMIMETICS FOR TREATMENT OF EYE DISEASE

#296
20230346948
2023-11-02

Lipid conjugated peptide inhibitors of PICK1

#297
20230346876
2023-11-02

IMPROVED WOUND CARE DEVICE

#298
20230346875
2023-11-02

Compositions and methods for improving bruising and rejuvenating skin

#299
20230346837
2023-11-02

PEPTIDES AND COMBINATION THEREOF FOR USE IN THE IMMUNOTHERAPY AGAINST CANCERS

#300
20230340025
2023-10-26

Treatments for Gastrointestinal Disorders